Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-005057
Filing Date
2025-11-14
Accepted
2025-11-14 16:24:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9760
2 JOINT FILING AGREEMENT p25-2394exhibit99.htm EX-99.1 4416
  Complete submission text file 0000902664-25-005057.txt   15873
Mailing Address 1001 10TH AVENUE SOUTH SUITE 216 NAPLES FL 34102
Business Address 1001 10TH AVENUE SOUTH SUITE 216 NAPLES FL 34102 239-384-9750
Pentwater Capital Management LP (Filed by) CIK: 0001425851 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Subject) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91200 | Film No.: 251486836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)